Package 16714-534-01

{"route": ["ORAL"], "spl_id": "1fab5d61-9784-4a57-9895-cb797fae1400", "openfda": {"nui": ["N0000175462", "M0015066", "N0000009947"], "upc": ["0316714534015"], "unii": ["G70B4ETF4S", "OTT9J7900I"], "rxcui": ["476556"], "spl_set_id": ["fbbc7b73-eddf-40b5-8ebb-7b3d9c42dba6"], "pharm_class_cs": ["Nucleosides [CS]"], "pharm_class_epc": ["Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]"], "pharm_class_moa": ["Nucleoside Reverse Transcriptase Inhibitors [MoA]"], "manufacturer_name": ["NorthStar RxLLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET, FILM COATED in 1 BOTTLE (16714-534-01)", "package_ndc": "16714-534-01", "marketing_start_date": "20220309"}], "brand_name": "Emtricitabine and tenofovir disoproxil fumarate", "product_id": "16714-534_1fab5d61-9784-4a57-9895-cb797fae1400", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]", "Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]", "Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]", "Nucleoside Reverse Transcriptase Inhibitors [MoA]", "Nucleoside Reverse Transcriptase Inhibitors [MoA]", "Nucleosides [CS]", "Nucleosides [CS]"], "product_ndc": "16714-534", "generic_name": "Emtricitabine and tenofovir disoproxil fumarate", "labeler_name": "NorthStar RxLLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Emtricitabine and tenofovir disoproxil fumarate", "active_ingredients": [{"name": "EMTRICITABINE", "strength": "200 mg/1"}, {"name": "TENOFOVIR DISOPROXIL FUMARATE", "strength": "300 mg/1"}], "application_number": "ANDA203442", "marketing_category": "ANDA", "marketing_start_date": "20220309", "listing_expiration_date": "20261231"}